The topoisomerase I inhibitory alkaloid camptothecin and its derivative topotecan can bind to the G-quadruplex enhancer of MYB, thus inhibiting the expression of MYB in K562 CML cells[219,220]. This evidence concerns the gene MYB and chronic myelogenous leukemia, BCR-ABL1 positive.